Zhou‐Li Cheng

机构：Jinshan Hospital of Fudan University · ORCID：0009-0002-1961-534X

发表论文 27 篇 · 总被引 1511 次 · h-index 13

代表论文

• SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer (2018 · EMBO Reports · 被引 284)
• Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma (2018 · Oncogene · 被引 225)
• Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses (2022 · Nature Cell Biology · 被引 216)
• Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth (2016 · Cancer Research · 被引 158)
• Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy (2023 · Science Advances · 被引 152)
• SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response (2018 · Cell Reports · 被引 124)